Pembroke Management, LTD
- SEC CIK
- 0001063497
- Latest filing
- Aug 13, 2026
The latest 13F from Pembroke Management, LTD covers Q2 2026 (filed Aug 13, 2026): 100 long positions worth $773.7M. The top 10 holdings make up 42.8% of the portfolio, and the largest is Everpure, Inc. (P) at 5.1%. Livermore has 24 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 15
- Est. +$51.7M
- Added
- 22
- Est. +$71.0M
- Reduced
- 59
- Est. −$82.8M
- Sold out
- 12
- Est. −$52.4M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $773.7M
- +$82.3M (+11.9%) vs. prior quarter
- Positions
- 100
- +3 vs. prior quarter
- Top 10 concentration
- 42.8%
- Top 10 as share of value
- Turnover
- 16.8%
- Q2 2026, one quarter
- Average holding period
- 10.3 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $1.36B (Q4 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026Amended | 100 | $773.7M | PMODAAON | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 97 | $691.4M | MPWRREZIMOD | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 12, 2026 | 92 | $967.9M | REZIGMEDMPWR | vs. Q3 2025 | SEC |
| Q3 2025 | Oct 28, 2025 | 89 | $1.01B | REZIPAAON | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 7, 2025 | 78 | $826.7M | CNMPMPWR | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 59 | $685.8M | GMEDCLBTIBP | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 31, 2025 | 60 | $802.0M | GMEDCLBTVERX | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 29, 2024 | 58 | $784.1M | IBPGMEDMPWR | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 1, 2024 | 62 | $744.4M | GMEDIBPMPWR | vs. Q1 2024 | SEC |
| Q1 2024 | May 8, 2024 | 61 | $849.9M | IBPCNMMPWR | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 13, 2024 | 62 | $805.5M | IBPMPWRGMED | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 8, 2023 | 58 | $732.4M | GMEDPIBP | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 27, 2023 | 63 | $928.0M | IBPGMEDMPWR | vs. Q1 2023 | SEC |
| Q1 2023 | May 3, 2023 | 63 | $914.5M | WNS Hldgs LtdCIGIMPWR | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 1, 2023 | 66 | $935.0M | GMEDWNS Hldgs LtdDOO | vs. Q3 2022 | SEC |
| Q3 2022 | Oct 24, 2022 | 66 | $900.9M | WNS Hldgs LtdGMEDCIGI | vs. Q2 2022 | SEC |
| Q2 2022 | Jul 26, 2022 | 64 | $967.2M | CIGIWNS Hldgs LtdDORM | vs. Q1 2022 | SEC |
| Q1 2022 | May 6, 2022 | 68 | $1.20B | GMEDCIGIWNS Hldgs Ltd | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 9, 2022 | 73 | $1.36B | CIGIWNS Hldgs LtdGMED | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 8, 2021 | 67 | $1.33B | CIGIGMEDWNS Hldgs Ltd | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 11, 2021Amended | 66 | $1.28B | CIGIGMEDWNS Hldgs Ltd | vs. Q1 2021 | SEC |
| Q1 2021 | May 6, 2021 | 65 | $1.20B | CIGIDOOTTEC | – | SEC |
13D and 13G filings
Companies where Pembroke Management, LTD reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
Pembroke Management, LTD does not currently report owning 5% or more of any company.
Latest filings
11 filings on file made by Pembroke Management, LTD or listing it as a reporting person, newest first.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| SANGSangoma Technologies Corp | Feb 2, 2024 | 13G/AOld format | – | – | – | SEC |
| BWMNBowman Consulting Group Ltd. | Feb 2, 2024 | 13G/AOld format | – | – | – | SEC |
| SANGSangoma Technologies Corp | Jan 13, 2023 | 13G/AOld format | – | – | – | SEC |
| FCFranklin Covey Co | Jan 13, 2023 | 13G/AOld format | – | – | – | SEC |
| BWMNBowman Consulting Group Ltd. | Jan 13, 2023 | 13GOld format | – | New | – | SEC |
| Points.com Inc. | Jul 11, 2022 | 13G/AOld format | – | – | – | SEC |
| Points.com Inc. | May 12, 2022 | 13G/AOld format | – | – | – | SEC |
| Points.com Inc. | Feb 1, 2022 | 13G/AOld format | – | – | – | SEC |
| FCFranklin Covey Co | Feb 1, 2022 | 13GOld format | – | New | – | SEC |
| SANGSangoma Technologies Corp | Feb 1, 2022 | 13GOld format | – | New | – | SEC |
| Points International Ltd | Feb 9, 2021 | 13G/AOld format | – | – | – | SEC |